Clinical trial
RU-486 in the Treatment of Bipolar Depression
NCT00359125 · University of British Columbia, Other · Withdrawn
Key facts
| NCT number | NCT00359125 |
|---|---|
| Title | RU-486 in the Treatment of Bipolar Depression |
| Official title | Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression. |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Western Economic Diversification Canada Stanley Medical Research Institute |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Depression |
| Intervention type | Drug, Other |
| Interventions | mifepristone (RU-486), Placebo |
| Enrollment | 0 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Aug 1, 2006 |
| Last update posted | Jan 22, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: